Risk of thyroid dysfunction during treatment with G-CSF

M E Van Hoef; A Howell

doi:10.1016/0140-6736(92)93206-3

Risk of thyroid dysfunction during treatment with G-CSF

M E Van Hoef, A Howell

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1169-70
Number of pages	2
Journal	Lancet (London, England)
Volume	340
Issue number	8828
DOIs	https://doi.org/10.1016/0140-6736(92)93206-3
Publication status	Published - 7 Nov 1992

Keywords

Autoantibodies
Female
Granulocyte Colony-Stimulating Factor
Humans
Thyroid Hormones
Thyroiditis, Autoimmune
Comment
Letter

Access to Document

10.1016/0140-6736(92)93206-3

Cite this

@article{00b6455ab8134d9e8a425e16ed42a8ab,

title = "Risk of thyroid dysfunction during treatment with G-CSF",

keywords = "Autoantibodies, Female, Granulocyte Colony-Stimulating Factor, Humans, Thyroid Hormones, Thyroiditis, Autoimmune, Comment, Letter",

author = "{Van Hoef}, {M E} and A Howell",

year = "1992",

month = nov,

day = "7",

doi = "10.1016/0140-6736(92)93206-3",

language = "English",

volume = "340",

pages = "1169--70",

journal = "Lancet (London, England)",

issn = "0140-6736",

publisher = "Elsevier BV",

number = "8828",

}

TY - JOUR

T1 - Risk of thyroid dysfunction during treatment with G-CSF

AU - Van Hoef, M E

AU - Howell, A

PY - 1992/11/7

Y1 - 1992/11/7

KW - Autoantibodies

KW - Female

KW - Granulocyte Colony-Stimulating Factor

KW - Humans

KW - Thyroid Hormones

KW - Thyroiditis, Autoimmune

KW - Comment

KW - Letter

U2 - 10.1016/0140-6736(92)93206-3

DO - 10.1016/0140-6736(92)93206-3

M3 - Article

C2 - 1279334

SN - 0140-6736

VL - 340

SP - 1169

EP - 1170

JO - Lancet (London, England)

JF - Lancet (London, England)

IS - 8828

ER -